Yarrow Bioscience, Inc. (YARW): Depreciation & Amortization
$23.0K
Year ended 2025-12-31
$23.0K
Trailing 12 months to 2026-06-30
-31.6%
3-year compound annual growth
-41.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $23.0K | +475.0% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $4.0K | n/a | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $72.0K | -33.9% | 2024-03-01, From 2022-01-01 |
| 2021-12-31 | $109.0K | -68.0% | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | $341.0K | -2.6% | 2022-03-17, From 2020-01-01 |
| 2019-12-31 | $350.0K | +9.7% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $319.0K | n/a | 2021-03-04, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $23.0K | +475.0% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $96.1K | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $615.7K | -11.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.9K | +71.3% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $9.77M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $87.8K | +15.3% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $491.8K | n/a |
| Medicinova Inc (MNOV) | 2025-12-31 | $20.1K | -4.6% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $24.0K | +242.9% |
Compare YARW, ELAB, QUCY, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗